Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Kallikrein 9 Antikörper (N-Term)

KLK9 Reaktivität: Human WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN545342
  • Target Alle Kallikrein 9 (KLK9) Antikörper anzeigen
    Kallikrein 9 (KLK9)
    Bindungsspezifität
    • 15
    • 7
    • 7
    • 6
    • 6
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 33
    • 17
    • 6
    Human
    Wirt
    • 49
    • 5
    Kaninchen
    Klonalität
    • 50
    • 4
    Polyklonal
    Konjugat
    • 21
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Kallikrein 9 Antikörper ist unkonjugiert
    Applikation
    • 31
    • 23
    • 19
    • 13
    • 13
    • 7
    • 6
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Verwendungszweck
    Rabbit polyclonal antibody raised against synthetic peptide of KLK9.
    Kreuzreaktivität
    Human
    Immunogen
    A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human KLK9.
    Top Product
    Discover our top product KLK9 Primärantikörper
  • Applikationshinweise
    ELISA (1:1000)
    Western Blot (1:100-500)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In PBS (0.09 % sodium azide)
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C. For long term storage store at -20°C.
    Aliquot to avoid repeated freezing and thawing.
  • Diamandis, Yousef, Luo, Magklara, Obiezu: "The new human kallikrein gene family: implications in carcinogenesis." in: Trends in endocrinology and metabolism: TEM, Vol. 11, Issue 2, pp. 54-60, (2001) (PubMed).

    Yousef, Kyriakopoulou, Scorilas, Fracchioli, Ghiringhello, Zarghooni, Chang, Diamandis, Giardina, Hartwick, Richiardi, Massobrio, Diamandis, Katsaros: "Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker." in: Cancer research, Vol. 61, Issue 21, pp. 7811-8, (2001) (PubMed).

    Yousef, Diamandis: "The expanded human kallikrein gene family: locus characterization and molecular cloning of a new member, KLK-L3 (KLK9)." in: Genomics, Vol. 65, Issue 2, pp. 184-94, (2000) (PubMed).

  • Target
    Kallikrein 9 (KLK9)
    Andere Bezeichnung
    KLK9 / Kallikrein-9 (KLK9 Produkte)
    Synonyme
    KLK-L3 antikoerper, KLKL3 antikoerper, 1200016C12Rik antikoerper, AI324041 antikoerper, Klk9 antikoerper, Klks3 antikoerper, rGK-9 antikoerper, rK9 antikoerper, kallikrein related peptidase 9 antikoerper, kallikrein related-peptidase 9 antikoerper, kallikrein 1-related peptidase C9 antikoerper, KLK9 antikoerper, Klk9 antikoerper, Klk1c9 antikoerper
    Gen-ID
    284366
    Pathways
    Komplementsystem
Sie sind hier:
Kundenservice